Similar Papers

Paper Title
Journal
Date
Author
Dosimetric Predictors of Radiotherapy-Induced Lymphocytopenia in Lung Cancer.
Nuradh Joseph ... Ananya Choudhury
Journal of Thoracic Oncology | VOL. 16
Nuradh Joseph, et. al.Nuradh Joseph ... Ananya Choudhury
01 Feb 2021
Polymorphisms of glutathione S-transferase genes and survival of resected hepatocellular carcinoma patients.
Kai Qu
World Journal of Gastroenterology | VOL. 21
Kai QuKai Qu
01 Jan 2015
Evaluation of the effect of cytoreductive surgery on survival in patients with solitary renal cell cancer metastasis
Dmitry V Semenov ... Mark I Gluzman
Urology reports (St. - Petersburg) | VOL. 13
Dmitry V Semenov, et. al.Dmitry V Semenov ... Mark I Gluzman
17 Nov 2023
Overexpression of members of the microRNA-183 family is a risk factor for lung cancer: A case control study
Wangyu Zhu ... Yanyan Hunag
BMC Cancer | VOL. 11
Wangyu Zhu, et. al.Wangyu Zhu ... Yanyan Hunag
15 Sep 2011
View more papers

More From: Endocrine Abstracts

Paper Title
Journal
Date
Author
Bilateral adrenal carcinoma: a rare case report
Qamar Al Tinawi ... Esra Demirtas
Endocrine Abstracts | VOL. -
Qamar Al Tinawi, et. al.Qamar Al Tinawi ... Esra Demirtas
26 Jan 2025
Outcome of combination chemotherapy for metastatic adrenocortical carcinoma
Joakim Crona ... Felix Beuschlein
Endocrine Abstracts | VOL. -
Joakim Crona, et. al.Joakim Crona ... Felix Beuschlein
26 Jan 2025
Clinical presentation, management, and outcomes of patients with small (≤ 4 cm) adrenocortical carcinoma: single-center retrospective cohort study
Torres, Md Camila A Villavicencio ... Irina Bancos Md
Endocrine Abstracts | VOL. -
Torres, Md Camila A Villavicencio, et. al.Torres, Md Camila A Villavicencio ... Irina Bancos Md
26 Jan 2025
Silent adrenal neoplasm masquerading as adrenocortical carcinoma in a patient with neurofibromatosis type 1
Alanoud Alaasmi ... Uzma Khan
Endocrine Abstracts | VOL. -
Alanoud Alaasmi, et. al.Alanoud Alaasmi ... Uzma Khan
26 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.